Current Efavirenz (EFV) or Ritonavir-Boosted Lopinavir (LPV/r) Use Correlates with Elevate Markers of Atherosclerosis in HIV-Infected Subjects in Addis Ababa, Ethiopia

• Rudolph L. Gleason Jr. ,

  * E-mail: rudy.gleason@me.gatech.edu

  Affiliations The George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, United States of America, The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, United States of America, The Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, United States of America

  ⨯
• Alexander W. Caulk,

  Affiliation The George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, United States of America

  ⨯
• Daniel Seifu,

  Affiliation Department of Biochemistry, Medical Faculty, Addis Ababa University, Addis Ababa, Ethiopia

  ⨯
• Ivana Parker,

  Affiliation The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, United States of America

  ⨯
• Brani Vidakovic,

  Affiliation The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, United States of America

  ⨯
• Helena Getenet,

  Affiliation Department of Internal Medicine, Medical Faculty, Addis Ababa University, Addis Ababa, Ethiopia

  ⨯
• Getachew Assefa,

  Affiliation Department of Radiology, Medical Faculty, Addis Ababa University, Addis Ababa, Ethiopia

  ⨯
• Wondwossen Amogne

  Affiliation Department of Internal Medicine, Medical Faculty, Addis Ababa University, Addis Ababa, Ethiopia

  ⨯